Literature DB >> 34936422

Inequities in Chlamydia trachomatis Screening Between Black and White Adolescents in a Large Pediatric Primary Care Network, 2015-2019.

Sarah Wood1, Jungwon Min1, Vicky Tam1, Julia Pickel1, Danielle Petsis1, Kenisha Campbell1.   

Abstract

Objectives. To identify associations between patient race and annual chlamydia screening among adolescent females. Methods. We performed a retrospective cohort study of females aged 15 to 19 years in a 31-clinic pediatric primary care network in Pennsylvania and New Jersey from 2015 through 2019. Using mixed-effect logistic regressions, we estimated associations between annual chlamydia screening and patient (race/ethnicity, age, previous chlamydia screening and infection, insurance type) and clinic (size, setting) characteristics. We decomposed potential effects of clinician's implicit racial bias and screening, using covariates measuring the proportion of Black patients in each clinician's practice. Results. There were 68 935 well visits among 37 817 females, who were 28.8% Black and 25.8% Medicaid insured. The mean annual chlamydia screening rate was 11.1%. Black females had higher odds of screening (adjusted odds ratio [AOR] = 1.67; 95% confidence interval [CI] = 1.51, 1.84) than did White females. In the clinician characteristics model, individual clinicians were more likely to screen their Black versus non-Black patients (AOR = 1.88; 95% CI = 1.65, 2.15). Conclusions. Racial bias may affect screening practices and should be addressed in future interventions, given the critical need to increase population-level chlamydia screening.(Am J Public Health. 2022;112(1):135-143. https://doi.org/10.2105/AJPH.2021.306498).

Entities:  

Mesh:

Year:  2022        PMID: 34936422      PMCID: PMC8713640          DOI: 10.2105/AJPH.2021.306498

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  31 in total

1.  Understanding sexual activity defined in the HEDIS measure of screening young women for Chlamydia trachomatis.

Authors:  Guoyu Tao; Cathleen M Walsh; Lynda A Anderson; Kathleen L Irwin
Journal:  Jt Comm J Qual Improv       Date:  2002-08

2.  Chlamydia screening and pelvic inflammatory disease: Insights from exploratory time-series analyses.

Authors:  Kwame Owusu-Edusei; Michele K Bohm; Harrell W Chesson; Charlotte K Kent
Journal:  Am J Prev Med       Date:  2010-06       Impact factor: 5.043

3.  Gonorrhea and chlamydia infection among women visiting family planning clinics: racial variation in prevalence and predictors.

Authors:  Lisa A Einwalter; Justine M Ritchie; Kevin A Ault; Elaine M Smith
Journal:  Perspect Sex Reprod Health       Date:  2005-09

4.  Addressing Systemic Racism Through Clinical Preventive Service Recommendations From the US Preventive Services Task Force.

Authors:  Chyke A Doubeni; Melissa Simon; Alex H Krist
Journal:  JAMA       Date:  2021-02-16       Impact factor: 56.272

5.  Chlamydia screening among females aged 15-21 years--multiple data sources, United States, 1999-2010.

Authors:  Karen W Hoover; Jami S Leichliter; Elizabeth A Torrone; Penny S Loosier; Thomas L Gift; Guoyu Tao
Journal:  MMWR Suppl       Date:  2014-09-12

6.  Variations in measurement of sexual activity based on EHR definitions.

Authors:  Elise D Berlan; Andrea M Ireland; Suzanne Morton; Sepheen C Byron; Benjamin D Canan; Kelly J Kelleher
Journal:  Pediatrics       Date:  2014-04-14       Impact factor: 7.124

7.  Human Immunodeficiency Virus, Chlamydia, and Gonorrhea Testing in New York Medicaid-Enrolled Adolescents.

Authors:  Li Yan Wang; Man-Huei Chang; Gale Burstein; Susan Hocevar Adkins
Journal:  Sex Transm Dis       Date:  2018-01       Impact factor: 2.830

8.  Using Provider Incentives and an Opt-Out Strategy in a Successful Quality Initiative to Increase Chlamydia Screening.

Authors:  Ahmed Elattma; Ellen Laves; Bret Taber; Kayla L Karvonen; Maria Christina Herrera; Eliza Hayes Bakken
Journal:  Jt Comm J Qual Patient Saf       Date:  2020-03-12

9.  The Estimated Direct Lifetime Medical Costs of Sexually Transmitted Infections Acquired in the United States in 2018.

Authors:  Harrell W Chesson; Ian H Spicknall; Adrienna Bingham; Marc Brisson; Samuel T Eppink; Paul G Farnham; Kristen M Kreisel; Sagar Kumar; Jean-François Laprise; Thomas A Peterman; Henry Roberts; Thomas L Gift
Journal:  Sex Transm Dis       Date:  2021-04-01       Impact factor: 2.830

10.  Relation between Chlamydia trachomatis infection and pelvic inflammatory disease, ectopic pregnancy and tubal factor infertility in a Dutch cohort of women previously tested for chlamydia in a chlamydia screening trial.

Authors:  Bernice M Hoenderboom; Birgit H B van Benthem; Jan E A M van Bergen; Nicole H T M Dukers-Muijrers; Hannelore M Götz; Christian J P A Hoebe; Arjan A Hogewoning; Jolande A Land; Marianne A B van der Sande; Servaas A Morré; Ingrid V F van den Broek
Journal:  Sex Transm Infect       Date:  2019-01-03       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.